Sheba Medical Center Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Ramat Gan Israel (1948)

Organization Overview

First Clinical Trial
2007
NCT00491634
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Bert W. Strassburger Lipid Center, Sheba Medical Center, Tel Hashomer | Department of Surgical Oncology, Sheba Medical Center | Dr. Avichai Shimoni MD | Dr. Ofir Harnoy MD | Jair Bar, M.D., Ph.D. | Prof.Avi Livneh | Shaba Medical Center

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 1)

Diabetic Nephropathies (Phase 2)

Kidney Diseases (Phase 2)

Leukemia (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Neoplasms (Phase 1)

Preleukemia (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 9
  • # of Trial APIs: 11